Healthscope Ltd shares sink lower on broker downgrade

The Healthscope Ltd (ASX:HSO) share price has come under pressure today after being downgraded by a leading broker…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Healthscope Ltd (ASX: HSO) share price has been amongst the worst performers on the market today with a decline of 3% to $1.82.

This latest decline means that the healthcare provider's shares have fallen over 20% since the start of the year.

Why are its shares lower today?

With no news out of the company, today's decline is likely to be in relation to a broker note out of Ord Minnett this morning.

According to the note, the broker has downgraded Healthscope's shares to a hold rating and cut the price target on its shares to $1.95.

Ord Minnett appears to be concerned that weak data released by APRA recently is a sign that the company could face greater-than-expected margin pressure in FY 2018.

Last week APRA advised that private hospital cover has fallen to its lowest level in over five years amid rising costs and delays in long-promised reforms.

While rival Ramsay Health Care Limited (ASX: RHC) has managed to avoid a downgrade, its shares are almost 3% lower today as investors consider the impact this will have on its business as well.

Should you buy either healthcare shares?

As I expect Healthscope's earnings growth could be flat at best in FY 2018 and perhaps even FY 2019, I wouldn't be a buyer of its shares today. Especially as they trade at a premium to the market-average at 18x trailing earnings.

But I would consider an investment in Ramsay Health Care. I believe its geographically diverse business goes some way to sheltering it from the declines in private hospital cover and its potential expansion opportunities should allow it to grow earnings at a solid rate over the long term.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »